HyperBranch Medical Technology Secures CE Marking for Dural Sealant

HyperBranch Medical Technology, a privately-held firm based in Durham, North Carolina, has secured the CE Mark approval to commence sales of Adherus AutoSpray Dural Sealant outside the U.S. Adherus AutoSpray is the first independent bioadhesive spray applicator, which is used for efficient delivery of dural sealant offered by HyperBranch.

The sealant is utilized in spine and cranial surgeries to avoid cerebrospinal fluid leaks that occur after the dural repair. Avoidance of cerebrospinal fluid leaks need to benefit the patient in certain post-surgical complications, like infection and leaks, leading to shorter hospital stays.

John Conn, President and CEO of HyperBranch, commented that Adherus AutoSpray is an innovative delivery system that removes complex preparation steps for the nurse and enables the surgeon to start and stop sealant dispensing in an accurate and effortless way without clogging issues. In addition to offering a watertight seal, Adherus AutoSpray Dural Sealant serves as an adhesion barrier to reduce scarring, remarked Conn. The product matches HyperBranch’s other neurosurgery products, including Adherus MIS and Adherus Dural Sealant. The company’s entire range of products has the same proprietary chemistry, which offers controlled performance and degrades gradually during the healing process. The Adherus sealants are biodegradable synthetic hydrogels, which undergo polymerization in a moist area and flow optimally based on the application.

Currently, HyperBranch has attained CE Marks for five of its products. A US feasibility study has been completed by the company and is about to complete the pivotal part for its cranial product, which is equipped with the new Autospray device.

Source: http://www.hyperbranch.com/

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 09). HyperBranch Medical Technology Secures CE Marking for Dural Sealant. AZoM. Retrieved on May 13, 2024 from https://www.azom.com/news.aspx?newsID=33012.

  • MLA

    Thomas, G.P.. "HyperBranch Medical Technology Secures CE Marking for Dural Sealant". AZoM. 13 May 2024. <https://www.azom.com/news.aspx?newsID=33012>.

  • Chicago

    Thomas, G.P.. "HyperBranch Medical Technology Secures CE Marking for Dural Sealant". AZoM. https://www.azom.com/news.aspx?newsID=33012. (accessed May 13, 2024).

  • Harvard

    Thomas, G.P.. 2019. HyperBranch Medical Technology Secures CE Marking for Dural Sealant. AZoM, viewed 13 May 2024, https://www.azom.com/news.aspx?newsID=33012.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.